Neurostimulation for Pediatric Obstructive Sleep Apnea.
Otolaryngol Clin North Am
; 57(3): 447-455, 2024 Jun.
Article
em En
| MEDLINE
| ID: mdl-38508882
ABSTRACT
Up to 80% of children with Down syndrome (DS) are affected by obstructive sleep apnea (OSA), and only 16% to 30% will have resolution of their OSA with adenotonsillectomy. Hypoglossal nerve stimulation is a well-established therapy for adults with OSA and was recently approved by the Food and Drug Administration for use in children with DS and residual OSA. There is robust experience with this therapy in adults that has led to well-established care pathways. However, given the challenges inherent to caring for a complex pediatric population, these pathways are not directly transferrable to children with DS.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Terapia por Estimulação Elétrica
/
Síndrome de Down
/
Apneia Obstrutiva do Sono
/
Nervo Hipoglosso
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article